United Capital Financial Advisors’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Buy
70,964
+5,404
+8% +$138K 0.01% 578
2025
Q4
$1.67M Buy
65,560
+6,468
+11% +$166K 0.01% 581
2025
Q3
$1.51M Buy
59,092
+3,082
+6% +$78.2K 0.01% 529
2025
Q2
$1.42M Buy
56,010
+2,652
+5% +$65.8K 0.01% 512
2025
Q1
$1.33M Buy
53,358
+44,156
+480% +$1.09M 0.01% 508
2024
Q4
$226K Buy
9,202
+596
+7% +$14.9K ﹤0.01% 978
2024
Q3
$221K Buy
+8,606
New +$217K ﹤0.01% 977
2024
Q2
Sell
-18,126
Closed -$450K 1067
2024
Q1
$450K Buy
18,126
+506
+3% +$12.5K ﹤0.01% 760
2023
Q4
$445K Buy
+17,620
New +$420K ﹤0.01% 754

Other funds holding IBDX

United Capital Financial Advisors's IBDX Position: Q1 2026 in Review

United Capital Financial Advisors increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 8.2% in Q1 2026, buying an estimated $138K and bringing the position to 70,964 shares worth $1.79M. The position accounts for 0.01% of the portfolio, ranked #578.

United Capital Financial Advisors first reported a position in IBDX in Q4 2023 and has held it in 9 quarters since. 221 funds tracked by Wall St. Rank hold IBDX as of Q1 2026.

  • United Capital Financial Advisors held 70,964 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $1.79M as of Q1 2026.
  • United Capital Financial Advisors bought 5,404 iShares iBonds Dec 2032 Term Corporate ETF shares in Q1 2026, an estimated $138K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.01% of United Capital Financial Advisors's portfolio in Q1 2026, its #578 holding.
  • United Capital Financial Advisors first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2023 and has held it in 9 quarters since.
  • 221 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q1 2026.

Based on United Capital Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.